If I Could Only Buy 2 High-Yield REITs Today
REITs have been in the penalty box for nearly 3.5 years now. This has opened up some highly compelling opportunities in the sector. I share my top 2 high-yield REIT picks right now.
REIT Roulette: Why I'm Overweight Net Lease
Diversification is key in REIT investing, mirroring my roulette strategy—spread bets across sectors for optimal risk-adjusted returns. Net lease REITs offer stability and steady dividends, outperforming residential mREITs over 15 years and thriving even in volatile environments. Current market trends and strong earnings support overweighting net lease REITs, with sector consolidation and potential rate cuts as additional tailwinds.
Tariffs Up, Inflation Down
US equity markets surged this week - extending a dramatic post "Liberation Day" rebound - after the White House announced a trade truce with China, while investors cheered surprisingly cool inflation data. Quelling one of the primary recession risks, the U.S. and China reached a surprising breakthrough in agreeing to slash tariffs to pre-retaliation levels during a 90-day negotiating period. More good news on the inflation front. Despite the broad-based tariff hikes in April, the critical CPI and the PPI both showed the lowest annual increase in inflation since 2021.
The REIT Way To SWAN With These 5 Monthly Dividend Payers
I highlight five SWAN (Sleep Well At Night) REITs that pay monthly dividends and offer strong balance sheets, attractive yields, and growth potential. Realty Income, Healthpeak, Agree Realty, LTC Properties, and STAG Industrial are my top picks, each with well-covered dividends and favorable valuations. I caution against Gladstone Land due to its unsustainable payout ratio and negative earnings trend, labeling its yield a potential 'sucker yield.'
Buy The Dip: 2 Blue-Chip High Yields Getting Way Too Cheap
I focus on buying high-quality, high-yielding dividend growth stocks. When they go on sale, I pounce. I share two that are trading at highly compelling opportunities after recent pullbacks.
Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849
Ideaya Biosciences, Inc. is advancing darovasertib in a phase 2/3 trial for HLA-A2-negative metastatic uveal melanoma patients, with mPFS data expected by end of 2025. Ideaya plans a phase 3 study of darovasertib as a neoadjuvant for uveal melanoma, starting in the first half of 2025. IDE849 is an ADC targeting DLL3 in SCLC and NETs, This program has two catalysts: phase 1 data in Q3 2025 and a new study in H2 2025.
Agree Realty: Premium Valuation, But Still Worth Considering
Agree Realty has outperformed peers and the S&P 500 since our last update, driven by a strong dividend yield and share price recovery. Even with the greater volatility that the broader market has been experiencing, ADC has remained resilient, but has moved to a premium valuation against peers. Despite a premium valuation, ADC's focus on quality tenants, steady AFFO growth, and strong balance sheet can justify it still being a worthwhile investment.
A Ranking Of Net-Lease REITs By Investment Spread For Q1 2025
In Q1 2025, VICI, GLPI, Agree, and Realty Income generated positive investment spreads and total returns exceeding their cost of equity, making them attractive investments. EPRT and STAG have negative investment spreads and total returns below their cost of equity, making them less favorable investment options. This analysis uses cap rates and the weighted average cost of capital to estimate investment spreads. We also compare total returns to the cost of equity to measure accretion.
Agree Realty: Outperforming Net Lease (Rating Downgrade)
Economic uncertainty and volatility in 2025 present long-term investment opportunities, especially in high-quality commercial real estate like ADC. ADC has a strong track record, with a compound annual return of over 12% since its 1994 IPO and consistent dividend growth. Despite ADC's impressive portfolio and balance sheet, current high valuations limit upside potential, making it prudent to hold rather than buy at $77 per share.
Agree Realty: Now That's What I Call A Serious Long-Term Investment
Agree Realty represents a defensive stock of high quality that investors should consider for long-term income generation because it offers a secure 4% dividend yield and resilient growth. The company has delivered a 4,000% total return since its inception and achieved a 277% total return during the last ten years. The company's exceptional portfolio, with a 99.2% occupancy rate and strategic acquisitions, alongside strong financials, underscores its investment appeal.
Boomers Are Buying 5 Safe Monthly Dividend Stocks Delivering Huge Passive Income
Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.
Agree Realty: The Steady Eddy Monthly Payer You Need Amidst Market Uncertainty
Agree Realty Corporation offers a solid monthly yield of nearly 3%, a recession-resistant portfolio, and astute management, making it a strong buy despite seeming expensive. Q1 2025 earnings showed robust performance with core FFO and revenue growth, driven by strategic investments and annual rent escalators. The REIT's low AFFO payout ratio of 72% and strong balance sheet with minimal debt until 2028 position ADC well for growth and stability.
